secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001193125-26-079163
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Treace Medical Q4 revenue $62.5M (-9% YoY); guides FY2026 revenue down 0-6%
---------------------------------------------------------------------------

- Q4 revenue $62.5M, down 9% YoY; net loss $(9.4)M vs $(0.5)M in prior year.
- FY2025 revenue $212.7M, up 2% YoY; net loss $(59.0)M vs $(55.7)M; adj. EBITDA loss $(3.9)M.
- Guidance: FY2026 revenue $200-212M (decline 0-6%); adj. EBITDA loss $4-6M.
- Cash used fell 46% to $27.3M in FY2025; active surgeons +6% to 3,337.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000119312526079163/0001193125-26-079163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000119312526079163/tmci-20260227.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-079163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer